Abstract
Post-stroke depression (PSD) is the most common and severe neuropsychiatric complication after stroke. However, the molecular mechanism of PSD is still unclear. Previous studies have identified peripheral blood and urine metabolites associated with PSD using metabolomics techniques. We searched and systematically summarized metabolites that may be involved in metabolic changes in peripheral blood and urine of patients with PSD from the Metabolite Network of Depression Database (MENDA) and other biomedical databases. MetaboAnalyst5.0 software was used for pathway analysis and enrichment analysis of differential metabolites, and subgroup analyses were performed according to tissue types and metabolomics techniques. We identified 47 metabolites that were differentially expressed between patients with and without PSD. Five differential metabolites were found in both plasma and urine, including L-glutamic acid, pyroglutamic acid, palmitic acid, L-phenylalanine, and L-tyrosine. We integrated these metabolites into metabolic pathways, and six pathways were significantly altered. These pathways could be roughly divided into three modules including amino acid metabolism, nucleotide metabolism, and glucose metabolism. Among them, the most significantly altered pathway was “phenylalanine metabolism” and the pathway containing the most associated metabolites was “aminoacyl-tRNA biosynthesis”, which deserve further study to elucidate their role in the molecular mechanism of PSD. In summary, metabolic changes in peripheral blood and urine are associated with PSD, especially the disruption of “phenylalanine metabolism” and “aminoacyl-tRNA biosynthesis” pathways. This study provides clues to the metabolic characteristics of patients with PSD, which may help to elucidate the molecular pathogenesis of PSD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and material
Datasets from this study are available from public database.
Code availability
Not applicable.
References
Ashe K, Kelso W, Farrand S, Panetta J, Fazio T, De Jong G et al (2019) Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments. Front Psychiatry 10:561. https://doi.org/10.3389/fpsyt.2019.00561
Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ et al (2020) Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls. Biol Psychiatry 87(5):409–418. https://doi.org/10.1016/j.biopsych.2019.08.016
Bujak R, Struck-Lewicka W, Markuszewski MJ, Kaliszan R (2015) Metabolomics for laboratory diagnostics. J Pharm Biomed Anal 113:108–120. https://doi.org/10.1016/j.jpba.2014.12.017
Cai W, Mueller C, Li YJ, Shen WD, Stewart R (2019) Post stroke depression and risk of stroke recurrence and mortality: A systematic review and meta-analysis. Ageing Res Rev 50:102–109. https://doi.org/10.1016/j.arr.2019.01.013
Chen JJ, Zhou CJ, Liu Z, Fu YY, Zheng P, Yang DY et al (2015) Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach. J Proteome Res 14(8):3382–3389. https://doi.org/10.1021/acs.jproteome.5b00434
Chen JJ, Xie J, Li WW, Bai SJ, Wang W, Zheng P et al (2019) Age-specific urinary metabolite signatures and functions in patients with major depressive disorder. Aging (albany NY) 11(17):6626–6637. https://doi.org/10.18632/aging.102133
Chen J, Lv YN, Li XB, Xiong JJ, Liang HT, Xie L et al (2021) Urinary Metabolite Signatures for Predicting Elderly Stroke Survivors with Depression. Neuropsychiatr Dis Treat 17:925–933. https://doi.org/10.2147/ndt.S299835
Cheng SY, Zhao YD, Li J, Chen XY, Wang RD, Zeng JW (2014) Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology 47:126–135. https://doi.org/10.1016/j.psyneuen.2014.05.006
Chiaroni P, Azorin JM, Bovier P, Widmer J, Jeanningros R, Barré A et al (1990) A multivariate analysis of red blood cell membrane transports and plasma levels of L-tyrosine and L-tryptophan in depressed patients before treatment and after clinical improvement. Neuropsychobiology 23(1):1–7. https://doi.org/10.1159/000118707
Das J, and G KR (2018) Post stroke depression: The sequelae of cerebral stroke. Neurosci Biobehav Rev 90:104–114 https://doi.org/10.1016/j.neubiorev.2018.04.005
Ding X, Liu R, Li W, Ni H, Liu Y, Wu D et al (2016) A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD). Metab Brain Dis 31(2):279–287. https://doi.org/10.1007/s11011-015-9748-z
Frank D, Kuts R, Tsenter P, Gruenbaum BF, Grinshpun Y, Zvenigorodsky V et al (2019) The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approach. Neuropharmacology 155:173–184. https://doi.org/10.1016/j.neuropharm.2019.05.035
Geng LY, Qian FY, Qian JF, Zhang ZJ (2017) The combination of plasma glutamate and physical impairment after acute stroke as a potential indicator for the early-onset post-stroke depression. J Psychosom Res 96:35–41. https://doi.org/10.1016/j.jpsychores.2017.01.006
Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE et al (2006) Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Res 148(2–3):111–120. https://doi.org/10.1016/j.pscychresns.2006.08.004
Hackett ML, Pickles K (2014) Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 9(8):1017–1025. https://doi.org/10.1111/ijs.12357
Han XM, Qin YJ, Zhu Y, Zhang XL, Wang NX, Rang Y et al (2019) Development of an underivatized LC-MS/MS method for quantitation of 14 neurotransmitters in rat hippocampus, plasma and urine: Application to CUMS induced depression rats. J Pharm Biomed Anal 174:683–695. https://doi.org/10.1016/j.jpba.2019.06.043
Hu Z, Fan S, Liu M, Zhong J, Cao D, Zheng P et al (2019) Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics. Neuropsychiatr Dis Treat 15:867–881. https://doi.org/10.2147/ndt.S192307
Jia J, Zhang H, Liang X, Dai Y, Liu L, Tan K et al (2021) Application of Metabolomics to the Discovery of Biomarkers for Ischemic Stroke in the Murine Model: a Comparison with the Clinical Results. Mol Neurobiol 58(12):6415–6426. https://doi.org/10.1007/s12035-021-02535-2
Jiang W, Gong L, Liu F, Ren Y, Mu J (2021) Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression. Front Cell Infect Microbiol 11:663967. https://doi.org/10.3389/fcimb.2021.663967
Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17(7):451–459. https://doi.org/10.1038/nrm.2016.25
Ke C, Pan CW, Zhang Y, Zhu X, Zhang Y (2019) Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review. Metabolomics 15(12):152. https://doi.org/10.1007/s11306-019-1615-1
Lai TW, Zhang S, Wang YT (2014) Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol 115:157–188. https://doi.org/10.1016/j.pneurobio.2013.11.006
Levada OA, Troyan AS (2018) Poststroke Depression Biomarkers: A Narrative Review. Front Neurol 9:577. https://doi.org/10.3389/fneur.2018.00577
Li B, Guo K, Zeng L, Zeng B, Huo R, Luo Y et al (2018) Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers. Transl Psychiatry 8(1):34. https://doi.org/10.1038/s41398-017-0078-2
Li Y, Zhang X, Chen L, Yang B, Sui R (2019) Cerebellar fastigial nucleus is involved in post-stroke depression through direct cerebellar-hypothalamic GABAergic and glutamatergic projections. Exp Ther Med 18(4):2885–2892. https://doi.org/10.3892/etm.2019.7913
Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79(4):1431–1568. https://doi.org/10.1152/physrev.1999.79.4.1431
Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK et al (2012) Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med 16(9):1961–1969. https://doi.org/10.1111/j.1582-4934.2012.01555.x
Lumbreras B, Porta M, Márquez S, Pollán M, Parker LA, Hernández-Aguado I (2008) QUADOMICS: an adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of ’-omics’-based technologies. Clin Biochem 41(16–17):1316–1325. https://doi.org/10.1016/j.clinbiochem.2008.06.018
Ma W, Song J, Wang H, Shi F, Zhou N, Jiang J et al (2019) Chronic paradoxical sleep deprivation-induced depression-like behavior, energy metabolism and microbial changes in rats. Life Sci 225:88–97. https://doi.org/10.1016/j.lfs.2019.04.006
MacDonald K, Krishnan A, Cervenka E, Hu G, Guadagno E, Trakadis Y (2019) Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review. Am J Med Genet B Neuropsychiatr Genet 180(2):122–137. https://doi.org/10.1002/ajmg.b.32680
Medeiros GC, Roy D, Kontos N, Beach SR (2020) Post-stroke depression: A 2020 updated review. Gen Hosp Psychiatry 66:70–80. https://doi.org/10.1016/j.genhosppsych.2020.06.011
Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov 16(7):472–486. https://doi.org/10.1038/nrd.2017.16
Nurnberger JI Jr, Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I et al (2014) Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiat 71(6):657–664. https://doi.org/10.1001/jamapsychiatry.2014.176
Ogawa S, Koga N, Hattori K, Matsuo J, Ota M, Hori H et al (2018) Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets. J Psychiatr Res 96:23–32. https://doi.org/10.1016/j.jpsychires.2017.09.014
Ormstad H, Verkerk R, Sandvik L (2016) Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker? J Mol Neurosci 58(1):102–108. https://doi.org/10.1007/s12031-015-0659-6
Pascoe MC, Skoog I, Blomstrand C, Linden T (2015) Albumin and depression in elderly stroke survivors: An observational cohort study. Psychiatry Res 230(2):658–663. https://doi.org/10.1016/j.psychres.2015.10.023
Pascoe MC, Crewther SG, Carey LM, Noonan K, Crewther DP, Linden T (2012) Homocysteine as a potential biochemical marker for depression in elderly stroke survivors. Food Nutr Res 56 https://doi.org/10.3402/fnr.v56i0.14973
Pu J, Yu Y, Liu Y, Tian L, Gui S, Zhong X et al (2020) MENDA: a comprehensive curated resource of metabolic characterization in depression. Brief Bioinform 21(4):1455–1464. https://doi.org/10.1093/bib/bbz055
Qureshi MI, Vorkas PA, Coupland AP, Jenkins IH, Holmes E, Davies AH (2017) Lessons from Metabonomics on the Neurobiology of Stroke. Neuroscientist 23(4):374–382. https://doi.org/10.1177/1073858416673327
Shi Y, Yang D, Zeng Y, Wu W (2017) Risk Factors for Post-stroke Depression: A Meta-analysis. Front Aging Neurosci 9:218. https://doi.org/10.3389/fnagi.2017.00218
Sidorov E, Bejar C, Xu C, Ray B, Reddivari L, Chainakul J et al (2020) Potential Metabolite Biomarkers for Acute Versus Chronic Stage of Ischemic Stroke: A Pilot Study. J Stroke Cerebrovasc Dis 29(4):104618. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104618
Strasser B, Sperner-Unterweger B, Fuchs D, Gostner JM (2017) Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms. Curr Top Behav Neurosci 31:95–115. https://doi.org/10.1007/7854_2016_23
Tang CZ, Zhang YL, Wang WS, Li WG, Shi JP (2016) Serum Levels of High-sensitivity C-Reactive Protein at Admission Are More Strongly Associated with Poststroke Depression in Acute Ischemic Stroke than Homocysteine Levels. Mol Neurobiol 53(4):2152–2160. https://doi.org/10.1007/s12035-015-9186-2
Teraishi T, Kajiwara M, Hori H, Sasayama D, Hidese S, Matsuo J et al (2018) (13)C-phenylalanine breath test and serum biopterin in schizophrenia, bipolar disorder and major depressive disorder. J Psychiatr Res 99:142–150. https://doi.org/10.1016/j.jpsychires.2018.01.019
Tian L, Pu J, Liu Y, Gui S, Zhong X, Song X et al (2020) Metabolomic analysis of animal models of depression. Metab Brain Dis 35(6):979–990. https://doi.org/10.1007/s11011-020-00574-7
Villa RF, Ferrari F, Moretti A (2018) Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacol Ther 184:131–144. https://doi.org/10.1016/j.pharmthera.2017.11.005
Wang X, Li YH, Li MH, Lu J, Zhao JG, Sun XJ et al (2012) Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. Eur Arch Psychiatry Clin Neurosci 262(1):33–38. https://doi.org/10.1007/s00406-011-0209-3
Wang M, Gui X, Wu L, Tian S, Wang H, Xie L et al (2020) Amino acid metabolism, lipid metabolism, and oxidative stress are associated with post-stroke depression: a metabonomics study. BMC Neurol 20(1):250. https://doi.org/10.1186/s12883-020-01780-7
Weckmann K, Labermaier C, Asara JM, Müller MB, Turck CW (2014) Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates. Transl Psychiatry 4(11):e481. https://doi.org/10.1038/tp.2014.119
Whyte EM, Mulsant BH (2002) Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 52(3):253–264. https://doi.org/10.1016/s0006-3223(02)01424-5
Xiao J, Zhang J, Sun D, Wang L, Yu L, Wu H et al (2016) Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis. Neuropsychiatr Dis Treat 12:1919–1925. https://doi.org/10.2147/ndt.S110613
Xie J, Han Y, Hong Y, Li WW, Pei Q, Zhou X et al (2020) Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics. Neuropsychiatr Dis Treat 16:2017–2024. https://doi.org/10.2147/ndt.S271990
Xu T, Lu C, Feng L, Fan LX, Sun J, Fan B et al (2019) Liquid chromatography-mass spectrometry-based urinary metabolomics study on a rat model of simulated microgravity-induced depression. J Pharm Biomed Anal 165:31–40. https://doi.org/10.1016/j.jpba.2018.11.058
Yang J, Jin W, Liu D, Zhong Q, Zhou T (2020a) Enhanced pseudotargeted analysis using a segment data dependent acquisition strategy by liquid chromatography-tandem mass spectrometry for a metabolomics study of liquiritin in the treatment of depression. J Sep Sci 43(11):2088–2096. https://doi.org/10.1002/jssc.202000107
Yang J, Yan B, Zhao B, Fan Y, He X, Yang L et al (2020b) Assessing the Causal Effects of Human Serum Metabolites on 5 Major Psychiatric Disorders. Schizophr Bull 46(4):804–813. https://doi.org/10.1093/schbul/sbz138
Zhang W, Zhang XA (2015) A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis. Cell Biochem Biophys 72(3):661–667. https://doi.org/10.1007/s12013-014-0472-9
Zhang C, Mo YY, Feng SS, Meng MW, Chen SY, Huang HM et al (2021) Urinary metabonomics study of anti-depressive mechanisms of Millettia speciosa Champ on rats with chronic unpredictable mild stress-induced depression. J Pharm Biomed Anal 205:114338. https://doi.org/10.1016/j.jpba.2021.114338
Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X et al (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 21(6):786–796. https://doi.org/10.1038/mp.2016.44
Zhou Y, Danbolt NC (2014) Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (vienna) 121(8):799–817. https://doi.org/10.1007/s00702-014-1180-8
Acknowledgements
This work was supported by the Natural Science Foundation Project of China (Grant no. 82002396) and the In-hospital Cultivation Fund of the First Affiliated Hospital of Chongqing Medical University (Grant Number: PYJJ2021-07).
Funding
This work was supported by the Natural Science Foundation Project of China (Grant no. 82002396) and the In-hospital Cultivation Fund of the First Affiliated Hospital of Chongqing Medical University (Grant Number: PYJJ2021-07).
Author information
Authors and Affiliations
Contributions
Haiyan Liu drafting and refining the manuscript. Haiyan Liu and Qinxiang Zhou collected the data. Haiyan Liu and Juncai Pu analyzed the data. Lining Yang, Juncai Pu and Dingqun Bai: critical reading of the manuscript. All of the authors have read and approved the manuscript.
Corresponding authors
Ethics declarations
Ethics approval
This study does not require ethical approval.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflicts of interest
All the authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liu, H., Pu, J., Zhou, Q. et al. Peripheral blood and urine metabolites and biological functions in post-stroke depression. Metab Brain Dis 37, 1557–1568 (2022). https://doi.org/10.1007/s11011-022-00984-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-00984-9